Common pharma compliance concerns cited by FDA warning letters
European Pharmaceutical Review
AUGUST 23, 2022
Warning letters issued by FDA can be an important source of data to study and analyse violations that occur in pharmaceutical manufacturing. Such studies can also help companies prepare for their upcoming inspections by enabling them to identify and rectify any issues.
Let's personalize your content